Stephens Upgrades Pacific Biosciences of California (PACB) to Overweight
Get Alerts PACB Hot Sheet
Price: $3.81 +2.42%
Rating Summary:
12 Buy, 8 Hold, 0 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
12 Buy, 8 Hold, 0 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Stephens upgraded Pacific Biosciences of California (NASDAQ: PACB) from Equal Weight to Overweight with a price target of $8.00.
For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.
Shares of Pacific Biosciences of California closed at $5.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Upgrades Xinte Energy Co Ltd (1799:HK) to Hold, 'cost cutting efforts likely to keep away from loss making'
- Hennes & Mauritz AB (HMB:SS) (HNNMY) PT Raised to SEK190 at RBC Capital, 'showing some promising signs '
- HSBC Downgrades Munich Re (MUV2:GR) (MURGY) to Reduce, 'dividend yield remains relatively low'
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!